Undetected, this "silent" liver disease can progress and may eventually lead to the need for a liver transplant. A free blood test can provide valuable insight into your risk for developing MASH.
80% of adults with MASH don't know they have it.
If you are overweight, have high cholesterol, diabetes, or high blood sugar, you are at greater risk of developing MASH.
When caught early, liver damage may be stopped—or even reversed—with lifestyle changes or medical intervention.
Choose your location, tell us a little about you, and book your appointment.
Complete your quick and easy blood draw. You’ll also receive your compensation of $45 for your time and travel.
A few weeks after your test, a member of our team will share your results, what they mean, and provide you with a copy to share with your doctor.
Liver Function Tests (LFT) and Enhanced Liver Fibrosis (ELF) – Blood tests to screen for liver disease and detect fibrosis.
Lp(a) - A genetically determined type of cholesterol that puts you at greater risk of heart disease
Lipid panel - Measures cholesterol and fats in your blood
A1c - An ongoing elevation of the sugar in your blood that negatively impacts your heart, blood vessels, kidneys, nerves, eyesight and more.
Creatinine / eGFR - Estimates kidney function by measuring how well your kidneys filter blood. High creatinine or low eGFR may signal kidney disease.
pTau - A protein that may measure your risk for developing Alzheimer's disease (Based on eligibility at select locations)
hsCRP - A high sensitivity protein that, if chronically elevated, can be associated with heart disease risk
Hear from others who have participated in the Future of Medicine program:
Testimonials provided by trial participants are personal experiences and do not necessarily represent the views of the trial sponsor or Care Access. They are not a substitute for medical advice, and the results of the trial may vary based on individual circumstances. Always consult with your healthcare provider before making any medical decisions.
Care Access is a health research company improving access to research that brings about new cures and treatment for diseases. The Future of Medicine program by Care Access provides no-cost health screenings and access to health research.
Care Access is a health research company improving access to research that brings about new cures and treatment for diseases. The Future of Medicine program by Care Access provides no-cost health screenings and access to health research.
Schedule your blood test and receive:
Screening participants may receive financial compensation for time and travel, including up to $45 upon completion of their first blood test.
MASH (metabolic dysfunction-associated steatohepatitis) is an advanced form of metabolic dysfunction-associated steatotic liver disease (MASLD) that commonly goes undetected until the liver is severely damaged and leads to serious consequences such as liver transplant.
The symptoms of MASH (metabolic dysfunction-associated steatohepatitis) include intense itching, abdominal swelling, easy bruising and bleeding, jaundice, and varicose veins. Behavior changes, confusion, and slurred speech are also symptoms of MASH.
There are no treatments for MASH (metabolic dysfunction-associated steatohepatitis) currently, but weight loss can reduce fat and inflammation of the liver. Researchers are working on treatments so consider joining a research study to help advance medicine for MASH. [Researchers are working on treatments so consider scheduling a free liver screening to learn about your liver health and gain first access to research participation.]
People who are at risk for MASH (metabolic dysfunction-associated steatohepatitis) are people older than 40, are obese, and who have certain genetic risk factors. Current research also shows people with Hispanic heritage are at greater risk.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the term for a range of conditions caused by a build-up of fat in the liver. Until 2023 it was called nonalcoholic fatty liver disease (NAFLD). This name change was to more accurately describe the conditions, it’s causes, and to improve awareness of the disease and its traits. MASH (metabolic dysfunction-associated steatohepatitis), formerly called nonalcoholic steatohepatitis (NASH), is a severe form of metabolic dysfunction-associated steatotic liver disease (MASLD).
Metabolic dysfunction-associated steatotic liver disease (MASLD) symptoms include itchy skin, abdominal swelling, shortness of breath, swelling of the legs, varicose veins, enlarged spleen, red palms, and jaundice.
